Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Article History

Received : 10-01-2021

Accepted : 27-01-2021



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 663

PDF Downloaded: 493


Management of intra operative priapism after spinal anesthesia with intravenous glycopyrrolate and intracorporeal injection of ultra low dose of phenylephrine- A case report


Full Text PDF


Case Report

Author Details : Tshering P Bhutia*, Neeraj Bhattarai, Tsewang D Bhutia, Rajni , Sonam D Bhutia

Volume : 8, Issue : 2, Year : 2021

Article Page : 349-351

https://doi.org/10.18231/j.ijca.2021.065



Suggest article by email

Get Permission

Abstract

Priapism following neuraxial anesthesia or general anesthesia is a rare but problematic event which may result in delay, complication or even cancellation of scheduled operations in urological endoscopic procedures. We present a case of successful management of intra operative priapism in a 32 years old male under spinal anesthesia posted for Ureteroscopic Lithotripsy (URSL) of bilateral ureteric stone. Different therapies for management of intra operative priapism have been quoted in the past like intracorporeal injection of vasopressors, dorsal penile nerve block, intravenous glycopyrrolate, intravenous ketamine/dexmedetomidine etc. In this case we treated with intravenous glycopyrrolate and intracorporeal injection of ultra low dose phenylephrine.

Keywords: Priapism, Spinal anesthesia, Phenylephrine, Glycopyrrolate.



How to cite : Bhutia T P , Bhattarai N , Bhutia T D , Rajni, Bhutia S D , Management of intra operative priapism after spinal anesthesia with intravenous glycopyrrolate and intracorporeal injection of ultra low dose of phenylephrine- A case report. Indian J Clin Anaesth 2021;8(2):349-351


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.